4.8 Article

SuperPred: update on drug classification and target prediction

Journal

NUCLEIC ACIDS RESEARCH
Volume 42, Issue W1, Pages W26-W31

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gku477

Keywords

-

Funding

  1. German Jose Carreras Leukaemia Foundation [DJCLS R 12/05]
  2. German Cancer Consortium (DKTK)
  3. German Cancer Research Center (DKFZ)
  4. German Cancer Research Center (DKFZ), Heidelberg 69120, Germany
  5. German Federal Ministry of Education and Research
  6. European Union Seventh Framework Programme SYNSYS (Synaptic Systems: dissecting brain function in health and disease) [242167]
  7. Immunotox project (BMBF) [031A268B]
  8. Berlin-Brandenburg research platform BB3R (BMBF) [031A262C]
  9. German Research Foundation (DFG) [GRK1772, GRK1360]

Ask authors/readers for more resources

The SuperPred web server connects chemical similarity of drug-like compounds with molecular targets and the therapeutic approach based on the similar property principle. Since the first release of this server, the number of known compound-target interactions has increased from 7000 to 665 000, which allows not only a better prediction quality but also the estimation of a confidence. Apart from the addition of quantitative binding data and the statistical consideration of the similarity distribution in all drug classes, new approaches were implemented to improve the target prediction. The 3D similarity as well as the occurrence of fragments and the concordance of physico-chemical properties is also taken into account. In addition, the effect of different fingerprints on the prediction was examined. The retrospective prediction of a drug class (ATC code of the WHO) allows the evaluation of methods and descriptors for a well-characterized set of approved drugs. The prediction is improved by 7.5% to a total accuracy of 75.1%. For query compounds with sufficient structural similarity, the web server allows prognoses about the medical indication area of novel compounds and to find new leads for known targets.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available